Logo image of AGFB.BR

AGFA-GEVAERT NV (AGFB.BR) Stock Fundamental Analysis

EBR:AGFB - Euronext Brussels - BE0003755692 - Common Stock - Currency: EUR

1.034  +0 (+0.39%)

Fundamental Rating

3

AGFB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 10 industry peers in the Health Care Technology industry. While AGFB seems to be doing ok healthwise, there are quite some concerns on its profitability. AGFB is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AGFB had negative earnings in the past year.
AGFB had a positive operating cash flow in the past year.
AGFB had negative earnings in 4 of the past 5 years.
AGFB had a negative operating cash flow in each of the past 5 years.
AGFB.BR Yearly Net Income VS EBIT VS OCF VS FCFAGFB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M

1.2 Ratios

The Return On Assets of AGFB (-6.69%) is worse than 70.00% of its industry peers.
The Return On Equity of AGFB (-31.51%) is worse than 70.00% of its industry peers.
Industry RankSector Rank
ROA -6.69%
ROE -31.51%
ROIC N/A
ROA(3y)-8.91%
ROA(5y)0.06%
ROE(3y)-32.3%
ROE(5y)1.63%
ROIC(3y)N/A
ROIC(5y)N/A
AGFB.BR Yearly ROA, ROE, ROICAGFB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100

1.3 Margins

In the last couple of years the Operating Margin of AGFB has declined.
AGFB has a worse Gross Margin (31.24%) than 80.00% of its industry peers.
In the last couple of years the Gross Margin of AGFB has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for AGFB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 31.24%
OM growth 3Y-1.64%
OM growth 5Y-16.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.28%
GM growth 5Y0.88%
AGFB.BR Yearly Profit, Operating, Gross MarginsAGFB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

AGFB does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AGFB has about the same amount of shares outstanding.
AGFB has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AGFB has a worse debt to assets ratio.
AGFB.BR Yearly Shares OutstandingAGFB.BR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
AGFB.BR Yearly Total Debt VS Total AssetsAGFB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

An Altman-Z score of 2.16 indicates that AGFB is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of AGFB (2.16) is better than 70.00% of its industry peers.
A Debt/Equity ratio of 0.59 indicates that AGFB is somewhat dependend on debt financing.
AGFB has a Debt to Equity ratio (0.59) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Altman-Z 2.16
ROIC/WACCN/A
WACC8.75%
AGFB.BR Yearly LT Debt VS Equity VS FCFAGFB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

AGFB has a Current Ratio of 1.99. This is a normal value and indicates that AGFB is financially healthy and should not expect problems in meeting its short term obligations.
AGFB's Current ratio of 1.99 is fine compared to the rest of the industry. AGFB outperforms 80.00% of its industry peers.
AGFB has a Quick Ratio of 1.14. This is a normal value and indicates that AGFB is financially healthy and should not expect problems in meeting its short term obligations.
AGFB's Quick ratio of 1.14 is in line compared to the rest of the industry. AGFB outperforms 60.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.99
Quick Ratio 1.14
AGFB.BR Yearly Current Assets VS Current LiabilitesAGFB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

More info and screens

3

3. Growth

3.1 Past

The earnings per share for AGFB have decreased strongly by -57.63% in the last year.
Looking at the last year, AGFB shows a decrease in Revenue. The Revenue has decreased by 0.00% in the last year.
AGFB shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.44% yearly.
EPS 1Y (TTM)-57.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.5%
Revenue 1Y (TTM)0%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.44%
Sales Q2Q%-3.2%

3.2 Future

Based on estimates for the next years, AGFB will show a very strong growth in Earnings Per Share. The EPS will grow by 54.87% on average per year.
The Revenue is expected to grow by 2.94% on average over the next years.
EPS Next Y112.7%
EPS Next 2Y71.82%
EPS Next 3Y54.87%
EPS Next 5YN/A
Revenue Next Year2.32%
Revenue Next 2Y2.46%
Revenue Next 3Y2.94%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AGFB.BR Yearly Revenue VS EstimatesAGFB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
AGFB.BR Yearly EPS VS EstimatesAGFB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 0.4 -0.4 0.6

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

AGFB reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 10.14, the valuation of AGFB can be described as very reasonable.
AGFB's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. AGFB is cheaper than 80.00% of the companies in the same industry.
AGFB's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.41.
Industry RankSector Rank
PE N/A
Fwd PE 10.14
AGFB.BR Price Earnings VS Forward Price EarningsAGFB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AGFB.BR Per share dataAGFB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
AGFB's earnings are expected to grow with 54.87% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y71.82%
EPS Next 3Y54.87%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AGFB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AGFA-GEVAERT NV

EBR:AGFB (6/17/2025, 5:29:31 PM)

1.034

+0 (+0.39%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)05-14 2025-05-14
Earnings (Next)08-27 2025-08-27
Inst Owners51.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap160.08M
Analysts75.56
Price Target1.19 (15.09%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.71%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)176.17%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.57%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 10.14
P/S 0.14
P/FCF N/A
P/OCF 80.04
P/B 0.55
P/tB 3.08
EV/EBITDA N/A
EPS(TTM)-0.58
EYN/A
EPS(NY)0.1
Fwd EY9.86%
FCF(TTM)-0.26
FCFYN/A
OCF(TTM)0.01
OCFY1.25%
SpS7.3
BVpS1.89
TBVpS0.34
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.69%
ROE -31.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 31.24%
FCFM N/A
ROA(3y)-8.91%
ROA(5y)0.06%
ROE(3y)-32.3%
ROE(5y)1.63%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-1.64%
OM growth 5Y-16.64%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.28%
GM growth 5Y0.88%
F-Score4
Asset Turnover0.82
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 104.88%
Cap/Sales 3.81%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.99
Quick Ratio 1.14
Altman-Z 2.16
F-Score4
WACC8.75%
ROIC/WACCN/A
Cap/Depr(3y)78.36%
Cap/Depr(5y)64.97%
Cap/Sales(3y)3.26%
Cap/Sales(5y)2.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.63%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%2.5%
EPS Next Y112.7%
EPS Next 2Y71.82%
EPS Next 3Y54.87%
EPS Next 5YN/A
Revenue 1Y (TTM)0%
Revenue growth 3Y-13.53%
Revenue growth 5Y-10.44%
Sales Q2Q%-3.2%
Revenue Next Year2.32%
Revenue Next 2Y2.46%
Revenue Next 3Y2.94%
Revenue Next 5YN/A
EBIT growth 1Y-327.27%
EBIT growth 3Y-14.94%
EBIT growth 5Y-25.35%
EBIT Next Year235.3%
EBIT Next 3Y67.32%
EBIT Next 5YN/A
FCF growth 1Y68.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y102.04%
OCF growth 3YN/A
OCF growth 5YN/A